Bio-thera Solutions

This early-stage study tested a new drug called BAT7104 in people with advanced cancers who had run out of standard treatment options. The main goal was to check the drug's safety, see how the body processes it, and look for early signs that it might help shrink tumors. Researche…

This study observed how well and how safely a medication called QLETLI worked for children and teenagers with severe plaque psoriasis. It followed 80 young patients in China for about 24 weeks to see if their skin cleared up. The goal was to gather real-world information on this …

This early-stage study tested a new experimental drug called BAT8006 in 216 patients with advanced solid tumors that had stopped responding to standard treatments. The main goal was to determine if the drug was safe and to find the highest dose patients could tolerate without sev…

This study tested if a new eye injection called BAT5906 works as well as the established drug Lucentis to control wet age-related macular degeneration (AMD), a leading cause of vision loss. Nearly 500 patients received monthly injections of either BAT5906 or Lucentis for a year t…

This was an early-stage study to test the safety and find the right dose of a new drug called BAT1308 for people with advanced solid tumors that had stopped responding to standard treatments. The study involved 59 participants with cancers like non-small cell lung cancer, liver c…

This was a first-in-human study to test the safety and find the right dose of a new drug called BAT6026 for patients with advanced solid tumors. It involved 30 adults whose cancer had progressed despite standard treatments. The main goal was to see how much of the drug patients c…